Trial Profile
Hypogonadal Patients with Crohn's Disease Benefit from Treatment with Testosterone – Further Data from an Ongoing, Long-Term, Observational Registry Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Crohn's disease; Hypogonadism
- Focus Therapeutic Use
- Sponsors Bayer
- 24 Aug 2015 New trial record